YGR121W-A Antibody

What is YGR121W-A and why is it significant in yeast research?

YGR121W-A is a gene encoding a protein in Saccharomyces cerevisiae (Baker's yeast), specifically in strain ATCC 204508/S288c. While the precise function requires further characterization, this protein represents an important target for understanding fundamental yeast cellular processes. Methodologically, researchers typically approach YGR121W-A studies through loss-of-function experiments, localization studies, and protein interaction mapping to establish its role in cellular pathways. When investigating this protein, it's critical to consider its context within the broader yeast proteome to accurately interpret experimental findings.

What are the specifications of commercially available YGR121W-A antibodies?

The primary commercially available YGR121W-A antibody is a rabbit polyclonal antibody (product code CSB-PA665580XA01SVG-2) with the following specifications:

This antibody is supplied with both positive control antigen and negative control pre-immune serum, facilitating experimental validation .

What are the optimal conditions for Western blot applications using YGR121W-A antibody?

For optimal Western blot results with YGR121W-A antibody, implement the following methodological approach:

• Sample preparation:

  • Harvest mid-log phase yeast cells (OD600 0.6-0.8) to ensure consistent protein expression

  • Lyse cells using glass bead disruption in buffer containing protease inhibitors

  • Clarify lysates by centrifugation (14,000×g for 10 minutes at 4°C)

  • Quantify protein concentration using Bradford or BCA assay

• Electrophoresis and transfer:

  • Load 20-40μg total protein per lane on 12-15% SDS-PAGE gels

  • Include recombinant YGR121W-A protein (provided with antibody) as positive control

  • Transfer to PVDF membrane (recommended over nitrocellulose for yeast proteins)

  • Verify transfer efficiency using reversible staining

• Antibody incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with YGR121W-A antibody at 1:1000-1:2000 dilution overnight at 4°C

  • Wash 4×10 minutes with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

  • Perform enhanced chemiluminescence detection

This protocol should be optimized for specific laboratory conditions and equipment .

How can I optimize ELISA protocols for detecting YGR121W-A protein?

For ELISA detection of YGR121W-A protein, implement this methodological approach:

• Plate preparation:

  • Coat 96-well plates with capture antibody (1-5μg/ml in carbonate buffer, pH 9.6)

  • Incubate overnight at 4°C

  • Wash 3× with PBS-T (PBS + 0.05% Tween-20)

  • Block with 1% BSA in PBS for 1-2 hours at room temperature

• Sample processing:

  • Prepare serial dilutions of standards using recombinant YGR121W-A protein

  • Process yeast lysates under non-denaturing conditions

  • Add standards and samples to wells and incubate for 2 hours at room temperature

• Detection:

  • Add detection antibody (biotinylated anti-YGR121W-A or alternative epitope)

  • Incubate with streptavidin-HRP conjugate

  • Develop with TMB substrate and measure absorbance at 450nm

  • Compare against standard curve for quantification

This approach draws from standard ELISA methodology adapted specifically for yeast proteins, with critical optimization steps highlighted for YGR121W-A detection .

What controls are essential when performing experiments with YGR121W-A antibody?

A robust experimental design requires the following controls when working with YGR121W-A antibody:

• Positive controls:

  • Recombinant YGR121W-A protein provided with antibody (200μg)

  • Lysate from wild-type yeast known to express YGR121W-A

  • Overexpression system for YGR121W-A if available

• Negative controls:

  • Pre-immune serum provided with antibody (1ml)

  • YGR121W-A knockout strain lysate

  • Secondary antibody-only control to detect non-specific binding

• Technical validation controls:

  • Loading control (e.g., anti-actin or anti-GAPDH antibody)

  • Competition assay with excess antigen to confirm specificity

  • Gradient of sample concentrations to confirm signal linearity

These controls enable reliable interpretation by establishing specificity, sensitivity, and quantitative accuracy .

How can I address non-specific binding when using YGR121W-A antibody in Western blots?

When encountering non-specific binding, implement this methodological troubleshooting approach:

• Blocking optimization:

  • Increase blocking time from 1 hour to 2-3 hours

  • Test alternative blocking agents (5% BSA, commercial blockers)

  • Add 0.1% Tween-20 to antibody diluent to reduce hydrophobic interactions

• Antibody parameters:

  • Titrate antibody concentration (test 1:500 to 1:5000 dilutions)

  • Pre-absorb antibody with yeast acetone powder from YGR121W-A knockout strain

  • Reduce incubation temperature to 4°C overnight instead of room temperature

• Washing protocol enhancement:

  • Increase wash duration (5×10 minutes instead of standard 3×5 minutes)

  • Use higher detergent concentration in wash buffer (0.1% vs. 0.05% Tween-20)

  • Implement a high-salt wash step (500mM NaCl) to disrupt low-affinity interactions

• Sample preparation refinement:

  • Include additional protease inhibitors to prevent degradation fragments

  • Filter lysates through 0.45μm filter to remove particulates

  • Pre-clear lysates with Protein A/G beads to remove components that bind non-specifically

This systematic approach addresses the most common causes of non-specific binding in yeast protein detection.

What approaches can resolve weak or absent signal when using YGR121W-A antibody?

For weak or absent signals, implement this methodological troubleshooting approach:

• Protein extraction optimization:

  • Evaluate multiple lysis methods (glass beads, enzymatic, mechanical disruption)

  • Include denaturation agents (8M urea, 2% SDS) if protein is difficult to extract

  • Concentrate proteins using TCA precipitation or similar methods

• Antibody sensitivity enhancement:

  • Reduce antibody dilution (1:500 or less)

  • Extend primary antibody incubation time to 48 hours at 4°C

  • Use signal amplification systems (biotinyl-tyramide amplification)

• Detection system optimization:

  • Switch to more sensitive substrate (e.g., femto-level chemiluminescent substrate)

  • Increase exposure time during imaging

  • Consider alternative detection methods (fluorescent secondaries with laser scanning)

• Expression conditions:

  • Verify expression timing and conditions for YGR121W-A

  • Test different growth phases and stress conditions that might upregulate expression

  • Consider protein stability and half-life when designing experiments

This comprehensive approach addresses potential issues at each stage of the experimental workflow.

How can YGR121W-A antibody be adapted for immunoprecipitation studies?

While YGR121W-A antibody is primarily validated for ELISA and Western blot applications, researchers can adapt it for immunoprecipitation with these methodological considerations:

• Immunoprecipitation protocol adaptation:

  • Pre-clear lysates with Protein A/G beads before antibody addition

  • Use 5-10μg antibody per 1mg total protein

  • Include mild detergents (0.1% NP-40 or 0.1% Triton X-100) to maintain protein interactions

  • Extend binding time to overnight at 4°C with gentle rotation

• Conjugation considerations:

  • Cross-link antibody to Protein A/G beads using dimethyl pimelimidate to prevent antibody co-elution

  • Consider direct antibody conjugation to magnetic beads for cleaner results

  • Implement stringent washing (increasing salt concentration in steps)

• Elution optimization:

  • Test different elution conditions (low pH, high pH, competitive elution with immunogenic peptide)

  • Consider native elution for functional studies or denaturing elution for interaction analysis

  • Analyze eluates by both silver staining and Western blot with a different YGR121W-A antibody or epitope

• Validation approaches:

  • Compare to results with epitope-tagged YGR121W-A

  • Perform reverse co-immunoprecipitation with identified interacting partners

  • Confirm specificity using YGR121W-A knockout controls

This methodological framework enables adaptation of the antibody beyond its validated applications .

What considerations are important when using YGR121W-A antibody for studying protein-protein interactions?

For protein interaction studies using YGR121W-A antibody, implement this methodological approach:

• Lysis condition optimization:

  • Use gentle lysis buffers (avoid strong detergents like SDS)

  • Include stabilizing agents (10% glycerol, 1mM DTT)

  • Test multiple salt concentrations to preserve different interaction strengths

• Cross-linking strategies:

  • Consider in vivo cross-linking with formaldehyde (0.1-1%) before lysis

  • Test chemical cross-linkers with different spacer lengths (DSS, DSP, DTBP)

  • Implement reversible cross-linkers to confirm interactions under different conditions

• Interaction validation approaches:

  • Perform reciprocal co-immunoprecipitation with antibodies against putative partners

  • Confirm interactions using orthogonal methods (yeast two-hybrid, proximity labeling)

  • Map interaction domains using truncation mutants

• Analysis considerations:

  • Implement mass spectrometry analysis of immunoprecipitated complexes

  • Distinguish direct from indirect interactions through in vitro binding assays

  • Assess interaction dynamics under different physiological conditions

This comprehensive approach enables reliable identification and characterization of YGR121W-A protein interaction networks.

How can researchers integrate YGR121W-A antibody studies with genomic and proteomic approaches?

For multi-omics integration with YGR121W-A antibody studies, implement this methodological framework:

• Correlation with transcriptomic data:

  • Compare protein levels (detected by antibody) with YGR121W-A mRNA levels

  • Analyze temporal relationships between transcription and translation

  • Identify potential post-transcriptional regulatory mechanisms

• Integration with interactome data:

  • Map immunoprecipitation results to published protein interaction networks

  • Identify enriched functional modules containing YGR121W-A

  • Prioritize validation targets based on network centrality measures

• Connection with phenotypic data:

  • Correlate YGR121W-A expression levels with phenotypic screens

  • Compare antibody-detected localization with high-throughput localization datasets

  • Analyze YGR121W-A levels across genetic perturbation libraries

• Implementation in systems biology models:

  • Use antibody-derived quantitative data to parameterize computational models

  • Develop predictive frameworks incorporating YGR121W-A function

  • Test model predictions with targeted experiments using the antibody

This integrated approach maximizes the value of YGR121W-A antibody data by placing it within broader biological contexts.

How should researchers design time-course experiments to study dynamic changes in YGR121W-A expression?

For time-course studies of YGR121W-A expression, implement this methodological approach:

• Experimental setup:

  • Synchronize yeast cultures using standard methods (α-factor arrest for mating type a cells)

  • Establish appropriate time intervals based on cell cycle duration (typically 15-30 minute intervals)

  • Include parallel samples for both protein and mRNA analysis at each timepoint

• Sampling and processing:

  • Implement rapid sampling techniques to capture transient changes

  • Process all samples with identical protocols to ensure comparability

  • Include internal spike-in controls for normalization across timepoints

• Quantification approach:

  • Use quantitative Western blotting with standard curves of recombinant protein

  • Implement image analysis software with appropriate background correction

  • Calculate relative expression changes normalized to invariant control proteins

• Validation strategy:

  • Confirm periodicity through multiple cell cycles

  • Perform parallel flow cytometry to correlate with cell cycle phases

  • Test consistency across different synchronization methods

This systematic approach enables reliable detection of dynamic changes in YGR121W-A expression patterns.

What approaches can be used to study post-translational modifications of YGR121W-A?

For studying post-translational modifications (PTMs) of YGR121W-A, implement this methodological framework:

• Modification-specific sample preparation:

  • Include phosphatase inhibitors (50mM NaF, 10mM Na₃VO₄) for phosphorylation studies

  • Add deubiquitinase inhibitors (PR-619, 1-10μM) for ubiquitination analysis

  • Use HDAC inhibitors (TSA, 400nM) for acetylation studies

• Separation and enrichment:

  • Implement Phos-tag SDS-PAGE for phosphorylated protein detection

  • Use IMAC (Fe³⁺-NTA) to enrich phosphopeptides before analysis

  • Apply ubiquitin remnant antibodies for enrichment of ubiquitinated fragments

• Detection strategies:

  • Perform Western blotting with modification-specific antibodies (anti-phospho, anti-ubiquitin)

  • Use mass spectrometry to map specific modification sites

  • Implement targeted SRM/MRM mass spectrometry for quantitative analysis

• Functional validation:

  • Generate site-specific mutants (S/T/Y to A for phosphorylation sites)

  • Test function under conditions that induce modifications

  • Correlate modification status with protein-protein interactions

This comprehensive approach enables detailed characterization of YGR121W-A post-translational modifications and their functional significance.

How can researchers effectively study YGR121W-A across different yeast genetic backgrounds?

For comparative studies across genetic backgrounds, implement this methodological approach:

• Antibody validation in each background:

  • Confirm antibody specificity in each strain using knockout controls

  • Test for cross-reactivity with homologous proteins in different strains

  • Optimize antibody concentration for consistent detection across strains

• Normalization strategy:

  • Identify and validate housekeeping proteins that maintain consistent expression across strains

  • Implement absolute quantification using standard curves of recombinant protein

  • Consider global normalization methods (total protein staining) for Western blots

• Comparative analysis:

  • Design experiments with paired wild-type controls for each genetic background

  • Account for differences in growth rates when comparing time-dependent processes

  • Implement statistical methods appropriate for multi-strain comparisons

• Interpretation framework:

  • Distinguish direct genetic effects from compensatory responses

  • Consider strain-specific post-translational modifications

  • Correlate expression differences with phenotypic variation between strains

This systematic approach enables reliable comparison of YGR121W-A expression, localization, and function across diverse yeast genetic backgrounds.